We are live on
!
Find out more
DA
Dillon & Associates Portfolio holdings
AUM
$726M
1-Year Est. Return
18.59%
This Fund
S&P 500
This Quarter
Est. Return
+10.02%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$551M
AUM Growth
+$31.7M
(+6.1%)
Cap. Flow
-$16.8M
Cap. Flow
% of AUM
-3.04%
Top 10 Holdings %
Top 10 Hldgs %
52.81%
Holding
80
New
3
Increased
18
Reduced
52
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rockwell Automation
ROK
|
+$2.27M |
| 2 |
Paycom
PAYC
|
+$2.07M |
| 3 |
NextEra Energy
NEE
|
+$1M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$787K |
| 5 |
Palo Alto Networks
PANW
|
+$769K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$3.45M |
| 2 |
RTX Corp
RTX
|
+$2.99M |
| 3 |
Apple
AAPL
|
+$1.83M |
| 4 |
NVIDIA
NVDA
|
+$1.51M |
| 5 |
Euronet Worldwide
EEFT
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 20.53% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Communication Services | 8.65% |
| 5 | Consumer Staples | 7.7% |
Similar funds
TC
F
SDH
SCM
MWP
FAN
TFHU
AGAM
Dillon & Associates's Q4 2023 Portfolio in Review
As of Q4 2023, Dillon & Associates held 80 positions worth $551M, up 6.1% from $520M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Dillon & Associates withdrew a net $16.8M in Q4 2023, closing 2 positions and reducing 52 holdings. Its most notable exit was Pacira BioSciences, an estimated $240K position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Dillon & Associates opened a new position in Rockwell Automation worth $2.51M.
- Dillon & Associates's largest Q4 2023 buy was Rockwell Automation: 8,095 shares worth $2.51M.
- Dillon & Associates added most to Paycom in Q4 2023, an estimated $2.07M increase.
- Dillon & Associates's biggest Q4 2023 reduction was PayPal, cutting an estimated $3.45M.
- Dillon & Associates fully exited Pacira BioSciences in Q4 2023, selling an estimated $240K.
- Dillon & Associates's ten largest holdings make up 53% of its $551M portfolio in Q4 2023.
- Dillon & Associates opened 3 new positions and closed 2 in Q4 2023.
- Dillon & Associates's portfolio value rose 6.1% quarter-over-quarter to $551M.
Based on Dillon & Associates's 13F filing for Q4 2023, filed 8 Feb 2024.